Dr Yongliang Zhang: MKP5, a novel regulator of IRF3-type I IFNs, critically modulates host-pathogen interaction in influenza and other RNA virus infections.

Add to your list(s) Download to your calendar using vCal

• Dr Yongliang Zhang, National University of Singapore
• Wednesday 07 October 2015, 12:30-13:30
• Lecture Theatre, Department of Pathology, Tennis Court Road.

If you have a question about this talk, please contact Sue Griffin.

Host: Prof John Trowsdale (jt233@cam.ac.uk)

MAPK phosphatases (MKPs), also known as dual-specificity phosphatases (DUSPs), are known as important regulators in both innate and adaptive immune responses, mainly through their regulation of MAP kinase activation. Previously, we have shown that MKP5 , one of the MKP proteins, is important for T helper cell activation and effector function by targeting JNK .

Our recent investigation on this protein reveals a novel function of MKP5 in innate immune response to infection of RNA viruses including influenza virus, vesicular stomatitis virus and Sendai virus. The interferon regulatory factor 3 (IRF3) is known as the master regulator of type I interferons (IFNs) which are essential for host defence against viral infection. We found that the expression MKP5 induced by virus infection inactivates IRF3 , thereby inhibiting type I IFN response.

Therefore, the induction of MKP5 expression could be part of the viral immune evasion strategies to escape the type I IFN response. At the same time, MKP5 could be a strategy of the host to regulate the intensity of antiviral immune response to avoid uncontrolled immunopathology.

This talk is part of the Immunology in Pathology series.

This talk is included in these lists:

• Biology
• Cambridge Immunology
• Cambridge Infectious Disease
• Cambridge Infectious Diseases
• Lecture Theatre, Department of Pathology, Tennis Court Road
• Life Sciences
• Life Sciences
• ME Seminar
• Pathology Seminars
• my_list
• other talks

Note that ex-directory lists are not shown.